Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
Nature Medicine2018Vol. 24(3), pp. 282–291
Citations Over TimeTop 1% of 2018 papers
Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun, David O’Sullivan, Simone Thomas, Miguel Waterhouse, Tony Andreas Müller, Kathrin Hanke, Sanaz Taromi, Petya Apostolova, Anna Lena Illert, Wolfgang Melchinger, Sandra Duquesne, Annette Schmitt‐Graeff, Lena Oßwald, Kaili Yan, Arnim Weber, Sònia Tugues, Sabine Spath, Dietmar Pfeifer, Marie Follo, Rainer Claus, Michael Lübbert, Christoph Rummelt, Hartmut Bertz, Ralph Wäsch, Johanna Haag, Andrea Schmidts, Michael Schultheiß, Dominik Bettinger, Robert Thimme, Evelyn Ullrich, Yakup Tanriver, Giang Lam Vuong, Renate Arnold, Philipp Hemmati, Dominik Wolf, Markus Ditschkowski, Cordula A. Jilg, Konrad Wilhelm, Christian Leiber, Sabine Gerull, Jörg Halter, Claudia Lengerke, Thomas Pabst, Thomas Schroeder, Guido Kobbe, Wolf Rösler, Soroush Doostkam, Stephan Meckel, Kathleen Stabla, Stephan Metzelder, Sebastian Halbach, Tilman Brummer, Zehan Hu, Jörn Dengjel, Björn Hackanson, Christoph Schmid, Udo Holtick, Christof Scheid, Alexandros Spyridonidis, Friedrich Stölzel, Rainer Ordemann, Lutz Müller, Flore Sicre-de-Fontbrune, Gabriele Ihorst, Jürgen Kuball, Jan E. Ehlert, Daniel Feger, Eva-Maria Wagner, Jean‐Yves Cahn, Jacqueline Schnell, Florian Kuchenbauer, Donald Bunjes, Ronjon Chakraverty, Simon Richardson, Saar Gill, Nicolaus Kröger, Francis Ayuk, Luca Vago, Fabio Ciceri, Antonia Müller, Takeshi Kondo, Takanori Teshima, Susan Klaeger, Bernhard Küster, Dennis Dong Hwan Kim, Daniel J. Weisdorf, Walter J. F. M. van der Velden, Daniela Dörfel, Wolfgang Bethge, Inken Hilgendorf, Andreas Hochhaus, Geoffroy Andrieux, Melanie Börries, Hauke Busch, John Magenau, Pavan Reddy, Myriam Labopin, Joseph H. Antin, Andrea Henden, Geoffrey R. Hill, Glen Kennedy, Merav Bar, Anita Sarma, Donal P. McLornan, Ghulam Mufti, Betül Oran, Katayoun Rezvani, Omid Shah, Robert S. Negrin, Arnon Nagler, Marco Prinz, Andreas Burchert, Andreas Neubauer, Dietrich W. Beelen, Andréas Mackensen, Nikolas von Bubnoff, Wolfgang Herr, Burkhard Becher, Gèrard Socié, Michael A. Caligiuri, Eliana Ruggiero, Chiara Bonini, Georg Häcker, Justus Duyster, Jürgen Finke, Erika L. Pearce, Bruce R. Blazar, Robert Zeiser
Related Papers
- → Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma(2021)11 cited
- The up-regulation of P62 levels is associated with resistance of sorafenib in hepatocarcinoma cells.(2019)
- Long-lasting tumour response to sorafenib therapy in advanced hepatocellular carcinoma.(2014)
- → Μελέτη της επιδράσεως του αντιαγγειογενετικού παράγοντα sorafenib στην ηπατική αναγέννηση(2015)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)